| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1474-4422(15)00153-2 |
| P698 | PubMed publication ID | 26213339 |
| P50 | author | Bruno Vellas | Q66877204 |
| Paul S. Aisen | Q30299891 | ||
| Simon Lovestone | Q30582986 | ||
| Nicola Coley | Q37836484 | ||
| P2093 | author name string | Sandrine Andrieu | |
| P2860 | cites work | Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling | Q21129475 |
| Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial | Q21136174 | ||
| Alzheimer's Disease | Q22248111 | ||
| Forecasting the global burden of Alzheimer’s disease | Q22252403 | ||
| Cholinesterase inhibitors for Alzheimer's disease | Q22252975 | ||
| Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease | Q24203739 | ||
| Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q24595802 | ||
| Effects of cognitive training interventions with older adults: a randomized controlled trial | Q24596660 | ||
| Long-term effects of cognitive training on everyday functional outcomes in older adults | Q24602305 | ||
| Testing the right target and right drug at the right stage | Q26864854 | ||
| I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy | Q28244849 | ||
| Vitamin D deficiency, cognitive impairment and dementia: a systematic review and meta-analysis | Q28270239 | ||
| 1α,25-Dihydroxyvitamin D3 reduces cerebral amyloid-β accumulation and improves cognition in mouse models of Alzheimer's disease | Q48778991 | ||
| A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial | Q50578805 | ||
| Effects of a multidomain lifestyle modification on cognitive function in older adults: an eighteen-month community-based cluster randomized controlled trial | Q50628247 | ||
| A controlled trial of homocysteine lowering and cognitive performance | Q50725116 | ||
| Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial | Q50725676 | ||
| A randomized controlled trial of dietetic interventions to prevent cognitive decline in old age hostel residents | Q50744434 | ||
| Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: the Cocoa, Cognition, and Aging (CoCoA) study | Q50746303 | ||
| Multifactorial vascular risk factor intervention to prevent cognitive impairment after stroke and TIA: a 12-month randomized controlled trial | Q50926022 | ||
| A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI. | Q50952335 | ||
| Complex mental and physical activity in older women and cognitive performance: a 6-month randomized controlled trial | Q51056748 | ||
| Understanding biomarkers of neurodegeneration: Novel approaches to detecting tau pathology. | Q53023257 | ||
| The role of estrogen in the treatment and prevention of dementia: introduction. | Q53219964 | ||
| Alzheimer disease. | Q53248108 | ||
| Designing a large prevention trial: statistical issues. | Q53259591 | ||
| Prevention trials in Alzheimer's disease: an EU-US task force report. | Q53428918 | ||
| Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761). | Q55067008 | ||
| Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease | Q57782086 | ||
| Alzheimer’s drugs take a new tack | Q74202356 | ||
| The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study | Q40437287 | ||
| Vitamins B(12), B(6), and folic acid for cognition in older men. | Q42879215 | ||
| Chronic endurance exercise training prevents aging-related cognitive decline in healthy older adults: a randomized controlled trial | Q43208343 | ||
| Regulatory innovation and drug development for early-stage Alzheimer's disease | Q43438827 | ||
| Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study | Q43570023 | ||
| Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress | Q43689443 | ||
| Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. | Q43906989 | ||
| Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial | Q44122322 | ||
| Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease | Q44438340 | ||
| Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial | Q44456433 | ||
| The European Dementia Prevention Initiative | Q44655081 | ||
| Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial | Q45028143 | ||
| Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study | Q45098641 | ||
| A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment | Q45292749 | ||
| Exergaming and older adult cognition: a cluster randomized clinical trial. | Q45339533 | ||
| An omnibus test for several hazard alternatives in prevention randomized controlled clinical trials | Q46129248 | ||
| Safety and efficacy of galantamine in subjects with mild cognitive impairment | Q46717012 | ||
| A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI study | Q46720790 | ||
| The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. | Q46870282 | ||
| Randomized controlled trial of a healthy brain ageing cognitive training program: effects on memory, mood, and sleep. | Q47787572 | ||
| The PACE study: a randomized clinical trial of cognitive activity strategy training for older people with mild cognitive impairment | Q47879412 | ||
| Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial | Q48187875 | ||
| Oxidative alterations in Alzheimer's disease | Q48283248 | ||
| Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial | Q48359732 | ||
| Brain amyloid imaging--FDA approval of florbetapir F18 injection | Q48395674 | ||
| Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study | Q48455136 | ||
| European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted | Q48527068 | ||
| Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial | Q28286628 | ||
| Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study | Q28302829 | ||
| The Alzheimer's disease neuroimaging initiative: progress report and future plans | Q28749585 | ||
| Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria | Q29614408 | ||
| Chronic disease long-term drug prevention trials: lessons from the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT). | Q30370713 | ||
| A cognitive training program based on principles of brain plasticity: results from the Improvement in Memory with Plasticity-based Adaptive Cognitive Training (IMPACT) study | Q30430555 | ||
| Ginkgo biloba for prevention of dementia: a randomized controlled trial | Q30437036 | ||
| Potential for primary prevention of Alzheimer's disease: an analysis of population-based data | Q30836810 | ||
| Disease-modifying therapies for Alzheimer disease: challenges to early intervention | Q31133189 | ||
| Alzheimer's disease: clinical trials and drug development | Q33349401 | ||
| CERAD practice effects and attrition bias in a dementia prevention trial | Q33574782 | ||
| The A4 study: stopping AD before symptoms begin? | Q33725775 | ||
| How should we deal with missing data in clinical trials involving Alzheimer's disease patients? | Q33796129 | ||
| Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial | Q34013637 | ||
| Using genetics to enable studies on the prevention of Alzheimer's disease | Q34038890 | ||
| Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. | Q34047968 | ||
| Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline | Q34113201 | ||
| The LIFE Cognition Study: design and baseline characteristics | Q34134812 | ||
| The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT) | Q34145516 | ||
| Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761 | Q34155629 | ||
| An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease | Q34364368 | ||
| Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE) | Q34403971 | ||
| Vitamin E and donepezil for the treatment of mild cognitive impairment | Q34411313 | ||
| The preclinical Alzheimer cognitive composite: measuring amyloid-related decline | Q34422469 | ||
| Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: the AIBL Active trial | Q34439105 | ||
| Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials | Q34457645 | ||
| Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease | Q34518915 | ||
| Nutrition in brain development and aging: role of essential fatty acids | Q34568335 | ||
| A randomized controlled trial of multicomponent exercise in older adults with mild cognitive impairment | Q34668003 | ||
| Biomarkers for Alzheimer's disease therapeutic trials | Q37815749 | ||
| Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease. | Q37943575 | ||
| Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin | Q37978026 | ||
| The potential use of hormone-based therapeutics for the treatment of Alzheimer's disease | Q37983631 | ||
| Calcium channel blockers and Alzheimer's disease: potential relevance in treatment strategies of metabolic syndrome | Q37989307 | ||
| Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial | Q38041758 | ||
| The global prevalence of dementia: a systematic review and metaanalysis | Q38073027 | ||
| A conceptual framework and ethics analysis for prevention trials of Alzheimer Disease. | Q38076634 | ||
| Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease | Q38116974 | ||
| Molecular links between Alzheimer's disease and diabetes mellitus | Q38122603 | ||
| Pathways to Alzheimer's disease | Q38205782 | ||
| Charting a path toward combination therapy for Alzheimer's disease | Q38300738 | ||
| The Mental Activity and eXercise (MAX) trial: a randomized controlled trial to enhance cognitive function in older adults | Q38453707 | ||
| Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial | Q38487526 | ||
| Design considerations in long-term intervention studies for the prevention of cognitive decline or dementia | Q38961343 | ||
| Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial | Q38961347 | ||
| A randomized double-blind trial of the effects of hormone therapy on delayed verbal recall in older women | Q39105871 | ||
| The worldwide economic impact of dementia 2010. | Q39488149 | ||
| A randomized controlled trial of cognitive training using a visual speed of processing intervention in middle aged and older adults. | Q34708302 | ||
| The coming acceleration of global population ageing | Q34737999 | ||
| A randomised controlled trial of aerobic exercise after transient ischaemic attack or minor stroke to prevent cognitive decline: the MoveIT study protocol | Q34799752 | ||
| Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial | Q34804070 | ||
| Mild cognitive impairment: ten years later | Q34847370 | ||
| Cocoa flavanol consumption improves cognitive function, blood pressure control, and metabolic profile in elderly subjects: the Cocoa, Cognition, and Aging (CoCoA) Study--a randomized controlled trial | Q35120244 | ||
| Extended results of the Alzheimer's disease anti-inflammatory prevention trial | Q35146385 | ||
| The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy ol | Q35533506 | ||
| Exercise, brain, and cognition across the life span | Q35562026 | ||
| A randomized controlled trial investigating the effect of Pycnogenol and Bacopa CDRI08 herbal medicines on cognitive, cardiovascular, and biochemical functioning in cognitively healthy elderly people: the Australian Research Council Longevity Interv | Q35847909 | ||
| Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy | Q35905639 | ||
| Preventing cognitive decline in older African Americans with mild cognitive impairment: design and methods of a randomized clinical trial | Q35992047 | ||
| Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's disease | Q36044265 | ||
| The age-dependent relation of blood pressure to cognitive function and dementia | Q36201875 | ||
| Resistance training and executive functions: a 12-month randomized controlled trial | Q36251917 | ||
| Dementia prevention: current epidemiological evidence and future perspective | Q36317775 | ||
| Risk of dementia in diabetes mellitus: a systematic review | Q36345254 | ||
| Effect of antihypertensive therapy on cognitive function in early executive cognitive impairment: a double-blind randomized clinical trial | Q36507890 | ||
| Effectiveness of cognitive training for Chinese elderly in Hong Kong | Q36627213 | ||
| A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE Trial | Q36797166 | ||
| Primary prevention and delay of onset of AD/dementia | Q36806653 | ||
| The projected effect of risk factor reduction on Alzheimer's disease prevalence | Q36825862 | ||
| Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS Cognitive and Affective sub study (KEEPS Cog) | Q37063691 | ||
| Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association | Q37069527 | ||
| Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial | Q37180577 | ||
| Dementia prevention: methodological explanations for inconsistent results | Q37263684 | ||
| Physical activity, diet, and risk of Alzheimer disease | Q37394712 | ||
| Therapeutic potential of statins in Alzheimer's disease. | Q37423422 | ||
| Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial | Q37574486 | ||
| Simulating effects of biomarker enrichment on Alzheimer's disease prevention trials: conceptual framework and example | Q37585688 | ||
| Estrogen therapy: is time of initiation critical for neuroprotection? | Q37618547 | ||
| Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease. | Q37703299 | ||
| National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline | Q37765090 | ||
| Estrogen therapy and Alzheimer's dementia. | Q37788767 | ||
| P433 | issue | 9 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| lessons learned | Q1673259 | ||
| P304 | page(s) | 926-944 | |
| P577 | publication date | 2015-07-23 | |
| P1433 | published in | Lancet Neurology | Q15755067 |
| P1476 | title | Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions | |
| P478 | volume | 14 |
| Q92854553 | A Population Perspective on Prevention of Dementia |
| Q55283322 | A preclinical perspective on the enhanced vulnerability to Alzheimer's disease after early-life stress. |
| Q36657393 | A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans |
| Q92347893 | AgeWell.de - study protocol of a pragmatic multi-center cluster-randomized controlled prevention trial against cognitive decline in older primary care patients |
| Q38806713 | Alzheimer's Disease is an Important Risk Factor of Fractures: a Meta-analysis of Cohort Studies. |
| Q92543622 | Alzheimer's Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials |
| Q37220592 | Amyloid biomarkers: pushing the limits of early detection |
| Q38628811 | Analytical Strategy to Prioritize Alzheimer's Disease Candidate Genes in Gene Regulatory Networks Using Public Expression Data |
| Q91642935 | Application of Big Data and Artificial Intelligence technologies to dementia prevention research: an opportunity for low-and-middle-income countries |
| Q38734416 | Association Between Periodontitis and Amyloid-β Peptide in Elderly People With and Without Cognitive Impairment |
| Q59811914 | Associations of lifestyle and vascular risk factors with Alzheimer's brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area |
| Q60950950 | Blood-Derived Plasma Protein Biomarkers for Alzheimer's Disease in Han Chinese |
| Q89304890 | Broadening the scope of epidemiologic dementia research |
| Q26766517 | Can physical exercise in old age improve memory and hippocampal function? |
| Q97529198 | Capsaicin consumption reduces brain amyloid-beta generation and attenuates Alzheimer's disease-type pathology and cognitive deficits in APP/PS1 mice |
| Q64119150 | Cognitive Training and Transcranial Direct Current Stimulation in Mild Cognitive Impairment: A Randomized Pilot Trial |
| Q39023945 | Cognitive Training in Parkinson's Disease |
| Q92323053 | Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife |
| Q34558884 | Dementia prevention, intervention, and care. |
| Q37741796 | Dementia: What pharmacists need to know |
| Q27007748 | Drug development in Alzheimer's disease: the path to 2025 |
| Q57149811 | Effect of Multidomain Intervention, Omega-3 Polyunsaturated Fatty Acids Supplementation or their Combinaison on Cognitive Function in Non-Demented Older Adults According to Frail Status: Results from the MAPT Study |
| Q40266298 | Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial |
| Q38836227 | Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial |
| Q38966308 | Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients. |
| Q55208569 | European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice? |
| Q57071918 | European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? |
| Q42279346 | Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly |
| Q28080008 | Is It Possible to Delay or Prevent Age-Related Cognitive Decline? |
| Q45428942 | Leisure time physical activity and dementia risk: a dose-response meta-analysis of prospective studies |
| Q51759841 | Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer's disease: a cross-sectional study of middle-aged adults from the broader New York City area. |
| Q57022760 | Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease |
| Q90113365 | Liraglutide Protects Against Brain Amyloid-β1-42 Accumulation in Female Mice with Early Alzheimer's Disease-Like Pathology by Partially Rescuing Oxidative/Nitrosative Stress and Inflammation |
| Q93162418 | Long-term Effects of Androgen Deprivation in a Patient with Spinal and Bulbar Muscular Atrophy - A Case Report with 14 Years of Follow-up |
| Q30275974 | Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease? |
| Q48248949 | MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden. |
| Q89499035 | Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer's Disease, and Dementia: From FINGER to World-Wide FINGERS |
| Q92513074 | N-of-1 Clinical Trials in Nutritional Interventions Directed at Improving Cognitive Function |
| Q58596304 | Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy |
| Q37688368 | Neuroprotective effects of CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer's disease model |
| Q38826506 | Non-pharmacological intervention for posterior cortical atrophy |
| Q36160395 | Orthostatic Hypotension and the Long-Term Risk of Dementia: A Population-Based Study |
| Q57039635 | Peripheral immune system in aging and Alzheimer's disease |
| Q54440823 | Pharmacotherapy for Vascular Cognitive Impairment. |
| Q91586758 | Physical Activity and Alzheimer's Disease: A Narrative Review |
| Q89459657 | Physical Exercise During Pregnancy Prevents Cognitive Impairment Induced by Amyloid-β in Adult Offspring Rats |
| Q61446706 | Prevalence of abnormal Alzheimer's disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples |
| Q50569036 | Preventing Alzheimer's disease is difficult |
| Q38719665 | Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives |
| Q57901947 | Prevention of dementia by targeting risk factors |
| Q90679436 | Prevention of dementia presents a potentially critical platform for improvement of long-term public health |
| Q39620240 | Promising Role of Neuromodulation in Predicting the Progression of Mild Cognitive Impairment to Dementia. |
| Q33570418 | Real benefit of a protective factor against dementia: Importance of controlling for death. Example of sport practice |
| Q46064566 | Reduce vascular risk to prevent dementia? |
| Q37145898 | Satisfaction With a Family-Focused Intervention for Mild Cognitive Impairment Dyads |
| Q91706991 | Sex and Gender Driven Modifiers of Alzheimer's: The Role for Estrogenic Control Across Age, Race, Medical, and Lifestyle Risks |
| Q60301953 | The Age-Well randomized controlled trial of the Medit-Ageing European project: Effect of meditation or foreign language training on brain and mental health in older adults |
| Q31147579 | The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement |
| Q37526374 | The Effects of Cognitive Training for Elderly: Results from My Mind Project |
| Q38815158 | The future of dementia risk reduction research: barriers and solutions |
| Q58725464 | The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease |
| Q89908888 | The possibility of vascular care for prevention of dementia |
| Q47567135 | The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset |
| Q26740007 | Therapies for Prevention and Treatment of Alzheimer's Disease |
| Q38901551 | Trends, Predictors, and Outcomes of Healthcare Resources Used in Patients Hospitalized with Alzheimer's Disease with at Least One Procedure: The Nationwide Inpatient Sample |
| Q64064247 | Web-Based Multidomain Lifestyle Programs for Brain Health: Comprehensive Overview and Meta-Analysis |
Search more.